Tidal Vision, a biotechnology company specializing in chitosan-based chemistries, has announced the successful completion of a US$ 140 million Series B financing round. The funding, which exceeded its original target due to high investor interest, will support the company’s efforts to expand its global infrastructure and advance the development of chitosan-based solutions across key industries.
The investment round attracted participation from several strategically aligned investors, including Cambridge Companies SPG, Eni Next (the corporate venture arm of Eni S.p.A), Milliken & Company, KIRKBI Climate, Convent Capital, SWEN Capital Partners’ Blue Ocean Fund, MBX Capital and Oman Investment Authority’s IDO Investments.
Strengthening Global Infrastructure
With the newly secured funding, Tidal Vision aims to scale up its production and research capabilities, further solidifying its role in the chitosan industry. The company plans to establish new facilities in Europe, Texas, and Ohio, significantly expanding its operational footprint. These new locations will allow for increased production capacities, ensuring a more robust and reliable supply of chitosan-based solutions to industries that rely on these biomolecular advancements.
Beyond physical expansion, Tidal Vision is set to allocate substantial resources to research and development. By advancing chitosan technologies and exploring adjacent innovations, the company seeks to improve the performance and economic viability of its solutions. This continued investment in R&D will contribute to the expansion of its intellectual property portfolio, reinforcing its position in the market.
“We are thrilled to have these strategically aligned capital partners onboard and supportive of accelerating our mission. We’ve already demonstrated it’s possible to make our biomolecular solutions outcompete. Now, we’re building infrastructure that’ll allow us to better serve customers who operate in critical industries providing the clean water, agriculture production, and materials necessary for everyday life.”
Investor Confidence and Industry Potential
The significant investor interest in the Series B round reflects confidence in Tidal Vision’s ability to drive innovation in chitosan-based chemistries. Filipp Chebotarev, Managing Partner and Chief Operating Officer (COO) at Cambridge Companies SPG, which led the investment round, highlighted the company’s growing influence.
“We’re pleased to have led this $140M Series B growth equity round for Tidal Vision. Tidal Vision is at the forefront of chitosan extraction, modification, characterization and commercial applications. These investments will enable the company to continue applying these crucial scientific breakthrough technologies commercially across a variety of sectors.”
Chitosan, a biopolymer derived from crustacean shells, has numerous applications across water treatment, agriculture, and material science. Its natural antimicrobial, biodegradable, and non-toxic properties make it an attractive alternative to conventional chemical solutions. With increasing global demand for sustainable and effective industrial solutions, Tidal Vision’s advancements in chitosan-based technologies are expected to play a crucial role in multiple sectors.
Also read: The Future of Farming: Global Agrotech Market Set to Soar Beyond $92 Billion by 2033
Expanding the Reach of Chitosan-Based Technologies
The infusion of capital will enable Tidal Vision to make chitosan-based solutions more accessible worldwide. By expanding its commercial-scale and R&D facilities, the company aims to streamline the adoption of its biomolecular technologies, making them more economical and efficient for industries that require sustainable alternatives.
Tidal Vision has been focused on developing scalable biomolecular solutions that align with environmental sustainability goals. The company continues to work toward a future where chitosan-based solutions are widely adopted, offering industries a sustainable and effective alternative to synthetic chemicals.
As Tidal Vision moves forward with its expansion plans, the completion of this funding round marks a crucial step in its journey to broaden the applications of chitosan-based technologies and strengthen its presence in the global market.
